2010
DOI: 10.1016/j.bmcl.2010.06.123
|View full text |Cite
|
Sign up to set email alerts
|

Refinement of the pharmacophore of 3,4-dihydroquinazoline-2(1H)-thiones for their anti-melanogenesis activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(15 citation statements)
references
References 26 publications
1
14
0
Order By: Relevance
“…Quinazolinones and their derivatives occur frequently in natural and synthetic pharmaceutical products. Such compounds act as inhibitors of inducible and neuronal nitric oxide synthases (Camacho et al, 2016), possess anti-melanogenesis activity (Thanigaimalai et al, 2010), inhibit aldosterone synthase (CYP11B) and act as antagonists of platelet activating factor (Walser et al, 1991; Grombein et al, 2015). In recent years, many studies have been directed toward the design of 3,4-dihydroquinazolin-2( 1H )-ones for the modulation of cardiotonic contractility (Campbell et al, 1988), inhibition of methionyl-tRNA synthetase (Buckner et al, 2015) and inhibition of HIV-1 Tat-TAR (Zeiger et al, 2014) together with the design of highly selective naked-eye sensors (Mei et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Quinazolinones and their derivatives occur frequently in natural and synthetic pharmaceutical products. Such compounds act as inhibitors of inducible and neuronal nitric oxide synthases (Camacho et al, 2016), possess anti-melanogenesis activity (Thanigaimalai et al, 2010), inhibit aldosterone synthase (CYP11B) and act as antagonists of platelet activating factor (Walser et al, 1991; Grombein et al, 2015). In recent years, many studies have been directed toward the design of 3,4-dihydroquinazolin-2( 1H )-ones for the modulation of cardiotonic contractility (Campbell et al, 1988), inhibition of methionyl-tRNA synthetase (Buckner et al, 2015) and inhibition of HIV-1 Tat-TAR (Zeiger et al, 2014) together with the design of highly selective naked-eye sensors (Mei et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…As can be seen from the Figure b, ellagic acid could effectively inhibit tyrosinase activity. Compared with arbutin (Thanigaimalai et al, ) ( IC 50 = 180 µM), amoxicillin (Chen et al, ) ( IC 50 = 900 µM), and hesperetin (Si et al, ) ( IC 50 = 11.25 ± 1.73 mM), the value of semi‐inhibitory rate of ellagic acid was 0.2 ± 0.05 mM. These results of activity assay showed that ellagic acid was an effective tyrosinase inhibitor.…”
Section: Resultsmentioning
confidence: 91%
“…Benzothiazines and 3,4-dihydroquinazoline-2-thiones are an important class of heterocyclest hat are prevalent in ag reat number of natural products and biologically activem olecules. [33][34][35][36] In this context, the Xu and Shen group developed catalyst-controlled solvent-free chemoselective syntheses of 2amino-3,1-benzothiazines 15 and 3,4-dihydroquinazoline-2-thiones 16 by using ortho-aminocinnamates 13 and isothiocyanates 14 (Scheme 11). They tested aw ide range of Lewis acids, including Yb(OTf) 3 ,S m(OTf) 3 3 ], and LiN(SiMe 3 ) 2 ,t oa ttemptt oa ttain exclusive chemoselectivity.…”
Section: Acid-catalyzed Thia-michaela Ddition Reactionsmentioning
confidence: 99%